Literature DB >> 3169107

Meta-analysis of clinical trials: summary of an international conference.

J P Boissel1, H S Sacks, A Leizorovicz, J Blanchard, E Panak, J C Peyrieux.   

Abstract

An international conference of clinicians, clinical investigators and biostatisticians discussed meta-analysis in relation to clinical trials, i.e. the combination of data from separate studies for the purpose of obtaining information that cannot be derived from the individual studies. Meta-analysis can be a helpful tool for generating hypotheses for future trials, for studying the consistency of trials of the same or similar goals, and for generating more precise estimates of effect. There are still a number of unresolved questions about the methodology and interpretation of meta-analysis. Better and more uniform reporting of primary studies would increase the usefulness of meta-analysis.

Mesh:

Year:  1988        PMID: 3169107     DOI: 10.1007/bf00615213

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  3 in total

1.  Perusing the literature: comparison of MEDLINE searching with a perinatal trials database.

Authors:  K Dickersin; P Hewitt; L Mutch; I Chalmers; T C Chalmers
Journal:  Control Clin Trials       Date:  1985-12

2.  Reporting on methods in clinical trials.

Authors:  R DerSimonian; L J Charette; B McPeek; F Mosteller
Journal:  N Engl J Med       Date:  1982-06-03       Impact factor: 91.245

3.  A method for assessing the quality of a randomized control trial.

Authors:  T C Chalmers; H Smith; B Blackburn; B Silverman; B Schroeder; D Reitman; A Ambroz
Journal:  Control Clin Trials       Date:  1981-05
  3 in total
  7 in total

Review 1.  [Meta-analysis as a tool for evaluation of evidence].

Authors:  A Koch; S Ziegler
Journal:  Med Klin (Munich)       Date:  2000-02-15

2.  Low molecular weight heparin in prevention of perioperative thrombosis.

Authors:  A Leizorovicz; M C Haugh; F R Chapuis; M M Samama; J P Boissel
Journal:  BMJ       Date:  1992-10-17

3.  GSTT1 null genotype contributes to lung cancer risk in asian populations: a meta-analysis of 23 studies.

Authors:  Xin Yang; Man-Tang Qiu; Jing-Wen Hu; Xiao-Xiao Wang; Feng Jiang; Rong Yin; Lin Xu
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

4.  Association of vitamin D receptor BsmI gene polymorphism with risk of tuberculosis: a meta-analysis of 15 studies.

Authors:  Yu-Jiao Wu; Xin Yang; Xiao-Xiao Wang; Man-Tang Qiu; Yi-Zhong You; Zhi-Xin Zhang; Shan-Mei Zhu; Lin Xu; Feng-Lei Tang
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

5.  Association of interleukin-18 gene promoter -607 C>A and -137G>C polymorphisms with cancer risk: a meta-analysis of 26 studies.

Authors:  Xin Yang; Man-Tang Qiu; Jing-Wen Hu; Feng Jiang; Ming Li; Jie Wang; Qin Zhang; Rong Yin; Lin Xu
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

6.  Association of matrix metalloproteinase-3 -1171(5A>6A) polymorphism with cancer risk: a meta-analysis of 41 studies.

Authors:  Xin Yang; Jing-Wen Hu; Man-Tang Qiu; Ming Li; Rong Yin; Jie Wang; Lin Xu; Qin Zhang
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

7.  Genetic polymorphisms of exon 1 of MBL2 contribute to tuberculosis risk especially in Asian populations: an updated meta-analysis of 26 studies.

Authors:  Yu-Jiao Wu; Xin Yang; Ting-di Chen; Zhi-Xin Zhang; Yi-Zhong You; Zheng-da Fan
Journal:  Infect Drug Resist       Date:  2018-08-20       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.